Repositioning the Role of DTx in the Industry

Repositioning the role of DTx is a complex and multifaceted task that requires addressing challenges related to reimbursement, alignment with public health priorities, clarity on pathways to market, and provider engagement. 

Reimbursement is a major hurdle with a lack of acceptance and understanding as contributing factors. To overcome this, DTx companies must demonstrate the value of their solutions and align them with therapy expectations. 

Join this meeting to discuss with your peers how to reposition DTx for success:  

• What are the expectations and needs of the market in the context of DTx, and how can these be better understood and met to foster successful partnerships and investments? 
• How can the reimbursement landscape be effectively navigated to ensure the successful integration and adoption of DTx? 
• What strategies can be employed to establish clear pathways to market for DTx, considering the unique regulatory and market access challenges they may face?   
• What are the key challenges and barriers that need to be addressed in repositioning the role of DTx within the healthcare industry?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.